MacNealy Hoover Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.18M Sell
34,572
-574
-2% -$20.9K 0.95% 39
2019
Q2
$1.45M Sell
35,146
-579
-2% -$23K 1.09% 38
2019
Q1
$1.44M Buy
35,725
+468
+1% +$18.7K 1.11% 35
2018
Q4
$1.46M Sell
35,257
-1,371
-4% -$56.9K 1.27% 30
2018
Q3
$1.53M Sell
36,628
-1,159
-3% -$44.6K 1.12% 34
2018
Q2
$1.3M Hold
37,787
1.01% 40
2018
Q1
$1.27M Sell
37,787
-665
-2% -$22.9K 1.02% 39
2017
Q4
$1.32M Sell
38,452
-2,688
-7% -$91.7K 0.95% 40
2017
Q3
$1.39M Sell
41,140
-211
-0.5% -$6.78K 1% 37
2017
Q2
$1.32M Buy
41,351
+475
+1% +$15K 1% 35
2017
Q1
$1.33M Sell
40,876
-442
-1% -$13.9K 1.01% 35
2016
Q4
$1.27M Sell
41,318
-580
-1% -$17.7K 0.98% 38
2016
Q3
$1.35M Sell
41,898
-948
-2% -$31.7K 1.08% 36
2016
Q2
$1.43M Sell
42,846
-1,014
-2% -$32.4K 1.15% 32
2016
Q1
$1.23M Sell
43,860
-316
-0.7% -$9.03K 1% 33
2015
Q4
$1.35M Buy
44,176
+2,491
+6% +$78.4K 1.14% 34
2015
Q3
$1.24M Hold
41,685
1.12% 34
2015
Q2
$1.33M Sell
41,685
-421
-1% -$13.7K 1.09% 36
2015
Q1
$1.39M Sell
42,106
-1,265
-3% -$40.2K 1.21% 36
2014
Q4
$1.28M Sell
43,371
-843
-2% -$24.2K 1.09% 37
2014
Q3
$1.24M Sell
44,214
-316
-0.7% -$8.87K 1.09% 37
2014
Q2
$1.25M Sell
44,530
-422
-0.9% -$12K 1.1% 38
2014
Q1
$1.37M Sell
44,952
-632
-1% -$18.8K 1.23% 34
2013
Q4
$1.32M Buy
+45,584
New +$1.33M 1.23% 31

Other funds holding PFE

MacNealy Hoover Investment Management's PFE Position: Q3 2019 in Review

MacNealy Hoover Investment Management reduced its Pfizer (PFE) stake by 1.6% in Q3 2019, selling an estimated $20.9K and leaving 34,572 shares worth $1.18M. The position accounts for 0.95% of the portfolio, ranked #39.

MacNealy Hoover Investment Management first reported a position in PFE in Q4 2013 and has held it in 24 quarters since. The position peaked at $1.53M in Q3 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • MacNealy Hoover Investment Management held 34,572 shares of Pfizer worth $1.18M as of Q3 2019.
  • MacNealy Hoover Investment Management sold 574 Pfizer shares in Q3 2019, an estimated $20.9K.
  • Pfizer made up 0.95% of MacNealy Hoover Investment Management's portfolio in Q3 2019, its #39 holding.
  • MacNealy Hoover Investment Management first reported a position in Pfizer in Q4 2013 and has held it in 24 quarters since.
  • MacNealy Hoover Investment Management's Pfizer position peaked at $1.53M in Q3 2018.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on MacNealy Hoover Investment Management's 13F filing for Q3 2019, filed 1 Oct 2019.